Potential Activity of Kynurenine Pathway Modulators for Multiple Sclerosis Targeted Therapeutics

被引：0
|
作者：
Sundaram, G. [1 ,2 ]
Lim, C. K. [1 ]
Brew, B. J. [2 ]
Guillemin, G. J. [1 ,2 ]
机构：
[1] Univ New S Wales, Dept Pharmacol & Physiol, Sch Med Sci, Sydney, NSW 2052, Australia
[2] St Vincents Hosp, St Vincents Ctr Appl Med Res, Darlinghurst, NSW 2010, Australia
来源：
MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：535 / 535
页数：1
相关论文
共 50 条
  • [11] Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression
    Chai K. Lim
    Ayse Bilgin
    David B. Lovejoy
    Vanessa Tan
    Sonia Bustamante
    Bruce V. Taylor
    Alban Bessede
    Bruce J. Brew
    Gilles J. Guillemin
    Scientific Reports, 7
  • [12] The serum kynurenine pathway metabolic profile is associated with overweight and obesity in multiple sclerosis
    Kupjetz, Marie
    Patt, Nadine
    Joisten, Niklas
    Ueland, Per Magne
    McCann, Adrian
    Gonzenbach, Roman
    Bansi, Jens
    Zimmer, Philipp
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 72
  • [13] Involvement of the Kynurenine Pathway in Multiple Sclerosis Progression: the Link between Neuroinflammation and Neurodegeneration
    Lim, C. K.
    Stankovic, R. K.
    Wu, W.
    Adams, S.
    Brew, B. J.
    Guillemin, G. J.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (04) : 534 - 535
  • [14] TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis
    Kuzmich, Nikolay N.
    Sivak, Konstantin V.
    Chubarev, Vladimir N.
    Porozov, Yury B.
    Savateeva-Lyubimova, Tatiana N.
    Peri, Francesco
    VACCINES, 2017, 5 (04)
  • [15] The Kynurenine Pathway and Inflammation in Amyotrophic Lateral Sclerosis
    Chen, Yiquan
    Stankovic, Roger
    Cullen, Karen M.
    Meininger, Vincent
    Garner, Brett
    Coggan, Sarah
    Grant, Ross
    Brew, Bruce J.
    Guillemin, Gilles J.
    NEUROTOXICITY RESEARCH, 2010, 18 (02) : 132 - 142
  • [16] Melatonin ameliorates disease severity in a mouse model of multiple sclerosis by modulating the kynurenine pathway
    Yahya Jand
    Mohammad Hossein Ghahremani
    Amir Ghanbari
    Shahram Ejtemaei-Mehr
    Gilles J. Guillemin
    Mahmoud Ghazi-Khansari
    Scientific Reports, 12
  • [17] Association between microglial activation and serum kynurenine pathway metabolites in multiple sclerosis patients
    Saraste, Maija
    Matilainen, Markus
    Rajda, Cecilia
    Galla, Zsolt
    Sucksdorff, Marcus
    Vecsei, Laszlo
    Airas, Laura
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 59
  • [18] The Kynurenine Pathway and Inflammation in Amyotrophic Lateral Sclerosis
    Yiquan Chen
    Roger Stankovic
    Karen M. Cullen
    Vincent Meininger
    Brett Garner
    Sarah Coggan
    Ross Grant
    Bruce J. Brew
    Gilles J. Guillemin
    Neurotoxicity Research, 2010, 18 : 132 - 142
  • [19] Melatonin ameliorates disease severity in a mouse model of multiple sclerosis by modulating the kynurenine pathway
    Jand, Yahya
    Ghahremani, Mohammad Hossein
    Ghanbari, Amir
    Ejtemaei-Mehr, Shahram
    Guillemin, Gilles J.
    Ghazi-Khansari, Mahmoud
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [20] Exercise Diminishes Plasma Neurofilament Light Chain and Reroutes the Kynurenine Pathway in Multiple Sclerosis
    Joisten, Niklas
    Rademacher, Annette
    Warnke, Clemens
    Proschinger, Sebastian
    Schenk, Alexander
    Walzik, David
    Knoop, Andre
    Thevis, Mario
    Steffen, Falk
    Bittner, Stefan
    Gonzenbach, Roman
    Kool, Jan
    Bloch, Wilhelm
    Bansi, Jens
    Zimmer, Philipp
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2021, 8 (03):
12345